Mission & Overview
Our mission is to transform oncology through precision-engineered microvesicles that deliver p53 mRNA directly to cancer cells. By utilizing a non-viral, immune-silent delivery platform, we bypass the limitations of traditional gene therapy to restore tumor suppression in advanced solid tumors.
Our Lead Candidate: ecm-RV/p53
- Genetically engineered cellular microvesicle (ecm) and non-viral RNA vesicle (RV)
- Loaded with our proprietary, in vitro transcribed p53 mRNA
Platform Technology
- Precision-engineered microvesicle architecture
- Ability to carry multiple types of payloads to power future pipeline expansions or partnerships